| 证券代码：603890 | 证券简称：春秋电子 | 公告编号：2026-015 | | --- | --- | --- | | 债券代码：113667 | 债券简称：春23转债 | | 受条件。具体内容详见公司于 2026 年 1 月 28 日披露于《中国证券报》《上海证 券报》和上海证券交易所网站（www.sse.com.cn）的《关于全资子公司全面要约 收购 Asetek A/S 全部股份的进展公告》（公告编号：2026-006）。 截至 2026 年 2 月 12 日 23:59（CET），因本次收购交易的交割条件尚未完 全满足，要约人已将要约期延长至 2026 年 3 月 2 日 23:59（CET），具体内容详 见公司于 2026 年 2 月 14 日披露于《中国证券报》《上海证券报》和上海证券交 易所网站（www.sse.com.cn）的《关于全资子公司全面要约收购 Asetek A/S 全 部股份的进展公告》（公告编号：2026-010）。 苏州春秋电子科技股份有限公司 关于全资子公司全面要约收购 Asetek A/S 全部股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 ...

| 证券代码：603890 | 证券简称：春秋电子 | 公告编号：2026-014 | | --- | --- | --- | | 债券代码：113667 | 债券简称：春23转债 | | 苏州春秋电子科技股份有限公司 关于全资子公司全面要约收购 Asetek A/S 全部股份的进展公告 截至 2026 年 3 月 2 日 23:59（CET），因本次收购交易的交割条件尚未完全 满足，要约人已将要约期延长至 2026 年 3 月 18 日 23:59（CET），具体内容详 见公司于 2026 年 3 月 5 日披露于《中国证券报》《上海证券报》和上海证券交 易所网站（www.sse.com.cn）的《关于全资子公司全面要约收购 Asetek A/S 全 部股份的进展公告》（公告编号：2026-011）。 截至 2026 年 3 月 18 日 23:59（CET），公司已获得江苏省商务厅出具的《企 业境外投资证书》（境外投资证第 N3200202600214 号）及昆山市发展和改革委 员会出具的《境外投资项目备案通知书》（昆发改外[2026]21 号），就本次收 购交易进行备案，但公司尚未完成外汇管理部门境外投 ...

| 证券代码：603890 | 证券简称：春秋电子 | 公告编号：2026-013 | | --- | --- | --- | | 债券代码：113667 | 债券简称：春23转债 | | 苏州春秋电子科技股份有限公司 关于控股股东部分股份质押、质押续期及解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 截至本公告披露之日，控股股东、实际控制人薛革文先生目前持有苏州 春秋电子科技股份有限公司（以下简称"公司"）股份 144,380,880 股， 持股比例为 32.31%。截至本公告披露日，其累计质押公司股份 23,720,000 股，占其所持有公司股份的 16.43%，占公司总股本的 5.31%。 公司于近日收到控股股东、实际控制人薛革文先生的通知，获悉其将所持有 公司的部分股份办理了质押、续期及解除质押业务，具体事项如下： 上述质押股份不存在被用作重大资产重组业绩补偿等事项的担保或其他保 障用途的情形。 二、本次股份质押续期的基本情况 2025 年 3 月，薛革文先生将其所持有的公司 2,500 ...

| 证券代码：603890 | 证券简称：春秋电子 | 公告编号：2026-012 | | --- | --- | --- | | 债券代码：113667 | 债券简称：春23转债 | | 苏州春秋电子科技股份有限公司 "春 23 转债"2026 年付息公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 苏州春秋电子科技股份有限公司（以下简称"公司"或"本公司"）于 2023 年 3 月 17 日向不特定对象发行的可转换公司债券（以下简称"本期债券"）将 于 2026 年 3 月 17 日（如该日为法定节假日或休息日，则顺延至下一个交易日， 顺延期间不另付息）开始支付自 2025 年 3 月 17 日至 2026 年 3 月 16 日期间的利 息。根据公司《苏州春秋电子科技股份有限公司向不特定对象发行可转换公司债 券募集说明书》（以下简称"《募集说明书》"）有关条款的规定，现将有关事 项公告如下： 一、本期债券的基本情况 可转债付息债权登记日：2026 年 3 月 16 日 可转债除息日：2026 年 3 月 ...

苏州春秋电子科技股份有限公司 截至 2026 年 1 月 26 日（CET），要约人已收到代表标的公司 286,800,265 股股份的接受，约占标的公司全部股本及所附投票权的 90.12%，已满足最低接 | 证券代码：603890 | 证券简称：春秋电子 | 公告编号：2026-011 | | --- | --- | --- | | 债券代码：113667 | 债券简称：春23转债 | | 关于全资子公司全面要约收购 Asetek A/S 全部股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏州春秋电子科技股份有限公司（以下简称"公司"）拟通过在新加坡设立 的全资子公司 CQXA Holdings. PTE. LTD（以下简称"要约人"）向在纳斯达克 哥本哈根交易所上市的 Asetek A/S（以下简称"标的公司"）全体股东发起自 愿性现金要约收购，拟收购标的公司不低于 90%的股份，包括可能要约收购标的 公司 100%的股份，使得标的公司退市（以下简称"本次收购交易"）。 截至本公告披露日，标的公司所有已发 ...

（文章来源：证券日报） 证券日报网讯 2月27日，春秋电子在互动平台回答投资者提问时表示，公司会按照相关法律法规要求， 及时披露收购进展情况，请持续关注公司公告。 ...

Core Viewpoint - The controlling shareholder of Spring Autumn Electronics, Xue Gewen, plans to reduce his stake in the company by up to 8,936,160 shares, representing no more than 2% of the total share capital, through block trading from March 17, 2026, to June 16, 2026, due to personal funding needs [1][2]. Group 1: Shareholder Information - Xue Gewen currently holds 144,380,880 shares, accounting for 32.31% of the company's total share capital [1][2]. - The planned reduction in shares is expected to yield approximately 138 million yuan based on the latest closing price of 15.42 yuan per share [2]. Group 2: Company Background - Spring Autumn Electronics was listed on the Shanghai Stock Exchange on December 12, 2017, with an initial public offering of 34.25 million shares at a price of 23.72 yuan per share, raising a total of approximately 812.41 million yuan [3]. - The company has a history of fundraising, including a non-public offering in 2021 that raised approximately 516 million yuan [4]. - The company issued 2.4 billion yuan in convertible bonds in 2020, which are traded on the Shanghai Stock Exchange [4]. - In 2023, the company issued 570 million yuan in convertible bonds, further diversifying its funding sources [5].

Summary of Key Points Core Viewpoint - Several leading companies across various industries have recently announced share repurchase plans, reflecting their confidence in long-term value and commitment to enhancing shareholder returns [11][22]. Group 1: Share Repurchase Plans - New Point Software completed a share repurchase of 1.8272 million shares, accounting for 0.57% of total shares, with a total expenditure of approximately 49.36 million yuan [1][16]. - Quzhou Dongfeng New Materials Group plans to repurchase shares worth between 50 million to 100 million yuan, with an upper price limit of 6.48 yuan per share, potentially acquiring 7.716 million to 15.432 million shares [3][12]. - Step Long Pharmaceutical completed a repurchase of 6.8564 million shares, representing 0.65% of total shares, with a total payment of approximately 118.5 million yuan [4][14]. - Huatai Medical announced a repurchase plan with a budget of 150 million to 200 million yuan, aiming to buy back 47,620 to 63,490 shares at a maximum price of 315 yuan per share [6][18]. - Hengtong Co., Ltd. plans to repurchase shares worth between 80 million to 100 million yuan, with a maximum price of 14.50 yuan per share, intending to cancel the repurchased shares [6][15]. Group 2: Shareholder Actions - Yinfeng Co. has repurchased 9.43 million shares, accounting for 2.14% of total shares, with a total expenditure of approximately 60.89 million yuan [7][12]. - Spring and Autumn Electronics announced the cancellation of 9.1369 million repurchased shares, reducing total shares from 456 million to 447 million [8][12]. - Yinzuo Co.'s major shareholder completed a share increase of 5.5066 million shares, representing 1.06% of total shares, with an expenditure of approximately 31.63 million yuan [8][12]. - Changshu Bank's executives have increased their holdings by 293,400 shares, with a total expenditure of approximately 2.07 million yuan [9][12]. Group 3: Industry Overview - The companies involved span various sectors, including software services, new materials, pharmaceutical manufacturing, medical devices, logistics, textile printing, consumer electronics, retail, and financial services [11][12]. - New Point Software is a leader in smart procurement, while Step Long Pharmaceutical is a key player in traditional Chinese medicine for cardiovascular diseases [11][18]. - Huatai Medical is recognized as a benchmark for domestic cardiovascular intervention devices, and Hengtong Co. is a core service provider in petrochemical logistics [11][18]. Group 4: Market Context - The share repurchase and increase actions occurred primarily between late January and early February 2026, coinciding with a traditionally sensitive period in the capital market [12][21]. - The actions taken by these companies contrast with the weak performance of the Hong Kong market, particularly in the internet technology sector, highlighting a proactive stance by these firms [22].

Core Viewpoint - On February 13, there were no announcements of share buybacks, but several companies announced share reductions, indicating a trend of selling among major stakeholders [1][3]. Group 1: Companies Announcing Share Reductions - Zhaolong Interconnect: Directors Song Hongxia and Deputy General Manager Shen Fuliang plan to reduce their holdings by 0.0110% [2][4]. - Gaoc测股份: The controlling shareholder and three directors plan to collectively reduce their holdings by up to 3.19% [2][4]. - ST Yigou: Shareholder Hangzhou Haoyue intends to reduce holdings by no more than 2.5% [2][4]. - Xiandao Jidian: Shareholder Sanlin Wanye plans to reduce holdings by up to 2.05% [2][4]. - Guanghuan Xinwang: The controlling shareholder Baihuida intends to reduce holdings by up to 3% [2][4]. - Chunqiu Electronics: The controlling shareholder Xue Gewen plans to reduce holdings by up to 2% [2][4]. - New Coordinates: Shareholders plan to collectively reduce holdings by up to 0.0795% [2][4]. - Zejing Pharmaceutical: Shareholders plan to collectively reduce holdings by up to 1.0385% [2][4].

春秋电子：正与客户合作研发镁合金人形机器人骨架等结构。 ...